Pharmaceuticals, Biotechnology and Life Sciences
LAVAL, Quebec–(BUSINESS WIRE)–#Altasciences–Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based…
– Approval based on statistically significant and clinically meaningful overall survival benefit demonstrated in the CELESTIAL phase 3 pivotal trial…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Robert J. Rosenthal, Ph.D., to the Company’s Board…
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…
Presented New Clinical Data from Phase 2 Study of SY-1425 in RARA-Positive Newly Diagnosed Unfit AML Patients at ESH Conference…
CHADDS FORD, Pa.–(BUSINESS WIRE)–MOBILion Systems, Inc., a life science company developing an advanced analytical instrument platform that efficiently identifies the…
Completed Submission of New Drug Application (NDA) to U.S. FDA for UGN-101 in Patients with Low-Grade Upper Tract Urothelial Cancer…
Funding expected to extend Company’s cash runway into 2021, well past its expected topline data readouts for global Phase 3…
Pharma industry’s leading R&D marketplace grows revenue by 1,522% over three years SAN DIEGO–(BUSINESS WIRE)–#fasterscience–Scientist.com, the world’s largest enterprise marketplace…